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Summary
Background Between 2000 and 2012 the number of multidrug-resistant (MDR) tuberculosis cases in the UK increased 
from 28 per year to 81 per year. We investigated the proportion of MDR tuberculosis cases arising from transmission 
in the UK and associated risk factors.
Method We identifi ed patients with MDR tuberculosis notifi ed in England, Wales, and Northern Ireland between 
Jan 1, 2004, and Dec 31, 2007, by linking national laboratory and surveillance data. Data for laboratory isolates, 
including drug sensitivities and 24-mycobacterial interspersed repetitive-unit-variable-number tandem repeat (MIRU-
VNTR) typing were obtained routinely from the National Tuberculosis Reference laboratories as part of national 
tuberculosis surveillance. We investigated clusters of cases with indistinguishable MIRU-VNTR profi les to identify 
epidemiological links. We calculated transmission using the n–1 method and established associated risk factors by 
logistic regression. We also assessed the likelihood of transmission to additional secondary active tuberculosis cases, 
identifi ed through conventional contact tracing.
Findings 204 patients were diagnosed with MDR tuberculosis in the study period; 189 (92·6%) had an MIRU-VNTR 
profi le. We identifi ed 12 clusters containing 40 individuals and 149 unique strains. The proportion of cases attributable to 
recent transmission, on the basis of molecular data, was 15% (40 cases clustered–12 clusters/189 with a strain type). The 
proportion of cases attributable to recent transmission (ie, transmission within the UK) after adjustment for 
epidemiological links was 8·5% (22 cases with epidemiological links–six clusters/189 cases with a strain type). Being UK 
born (odds ratio 4·81; 95% CI 2·03–11·36, p=0·0005) and illicit drug use (4·75; 1·19–18·96, p=0·026) were signifi cantly 
associated with clustering. The most common transmission setting was the household but 21 of 22 of epidemiological 
links were missed by conventional contact tracing. 13 secondary active tuberculosis cases identifi ed by conventional 
contact tracing were mostly contacts of patients with MDR tuberculosis from countries of high tuberculosis burden. 
11 (85%) of 13 shared the same country of birth as the index case, of whom ten did not share a strain type or drug 
resistance pattern.
Interpretation Transmission of MDR tuberculosis in the UK is low and associated with being UK born or illicit drug 
use. MIRU-VNTR typing with cluster investigation was more successful at identifying transmission events than 
conventional contact tracing. Individuals with tuberculosis who have had contact with a known MDR tuberculosis 
source case from a country of high tuberculosis burden should have drug-sensitivity testing on isolates to ensure 
appropriate treatment is given.
Funding Public Health England.
Introduction
In 2012, WHO estimated that 450 000 new cases of 
multidrug resistant (MDR) tuberculosis—defi ned as 
Mycobacterium tuberculosis resistant to at least isoniazid 
and rifampicin—occurred worldwide.1 Although there is 
little evidence to suggest that patients with MDR 
tuberculosis are more infectious than those with fully 
sensitive tuberculosis,2 the longer period during which 
these patients remain infectious provides greater 
opportunity for transmission. Additionally, people who 
acquire MDR tuberculosis strains develop disease with a 
poor prognosis, increasing the importance of tackling 
transmission of these strains. Understanding the 
transmission dynamics of MDR tuberculosis will help 
inform future tuberculosis control strategies.
In the UK, the number of MDR tuberculosis cases has 
increased substantially in the past decade from 28 cases 
in 2000 to 81 cases in 2012 (an increase from 0·9% to 
1·6% of all cases).3 Most individuals with MDR 
tuberculosis in the UK were born in sub-Saharan Africa 
or the Indian subcontinent but the proportion of cases of 
tuberculosis that are MDR is highest in the eastern 
European population,3 which is indicative of the global 
situation.1 Mycobacterial interspersed repetitive-unit–
variable-number tandem repeat (MIRU-VNTR) strain 
typing is a useful method for rapid detection of patients 
infected with the same strain of M tuberculosis, which 
might result from recent transmission (ie, within the 
previous 2 years). A previous analysis4 with 15 loci MIRU-
VNTR strain typing estimated that 19% of MDR 
Lancet Infect Dis 2014; 
14: 406–15
Published Online
March 4, 2014
http://dx.doi.org/10.1016/
S1473-3099(14)70022-2
Copyright © Anderson et al. 
Open Access article distributed 
under the terms of CC BY-NC-ND
This online publication 
has been corrected. 
The corrected version 
fi rst appeared at 
thelancet.com/infection on 
April 21, 2014
See Comment page 364
Public Health England, 
Respiratory Diseases 
Department, TB Section, 
Colindale, London, UK 
(L F Anderson PhD, 
S Tamne RN, D Zenner MD, 
Prof I Abubakar FRCP); Public 
Health England, National 
Mycobacterial Reference 
Laboratory, Centre for 
Immunology and Infectious 
Disease, Barts and The London 
School of Medicine and 
Dentistry, London, UK 
(T Brown PhD); Department of 
Respiratory Medicine, Leeds 
General Infi rmary, Leeds, UK 
(J P Watson FRCP); TB Health 
Visiting Service, Leeds 
Community Healthcare, 
Leeds, UK (C Mullarkey RN); 
and Research Department 
of Infection and Population 
Health, University College 
London, London, UK 
(Prof I Abubakar, D Zenner)
Correspondence to:
Dr Laura F Anderson, 
Public Health England, 
Respiratory Diseases 
Department, TB Section, 
Colindale, London, UK
laura.anderson@phe.gov.uk
Articles
www.thelancet.com/infection   Vol 14   May 2014 407
tuberculosis in the UK was attributable to recent 
transmission. This estimate was based on a short 
observation period (2004–05), and data for epidemiological 
links were scarce. A study of extensively drug-resistant 
(XDR) tuberculosis did not identify evidence of 
transmission in the UK.5
In this study, we combined 24 loci MIRU-VNTR strain 
typing with epidemiological data collected routinely in the 
surveillance system and through a cluster investigation 
questionnaire, which was devised to identify potential 
epidemiological links between cases. We aimed to 
establish the proportion of MDR tuberculosis cases 
attributable to transmission in the UK between 2004 and 
2007 and to identify associated risk factors. We used 
information obtained from contact investigations to 
identify additional secondary active tuberculosis cases and 
to subsequently assess the eﬀ ectiveness of conventional 
contact tracing for identifi cation of true transmission 
events, in the absence of routine strain typing. 
Methods
Study population
We included all patients with culture-confi rmed MDR 
tuberculosis notifi ed between Jan 1, 2004, and Dec 31, 
2007, in England, Wales, and Northern Ireland in this 
study.
Public Health England has the right under Section 60 
of the National Health Service Act 2006 and approval 
from the National Information Governance Board to 
hold and analyse national surveillance data for the 
purposes of protection of public health and for infectious 
disease surveillance; as such, these analyses did not 
require separate ethics approval.
Data collection
We identifi ed patients with MDR tuberculosis by matching 
laboratory isolates to case reports in the enhanced 
tuberculosis surveillance system.6 This system contains 
demographic (age, sex, country of birth, ethnicity, years 
since entry to the UK, and address) and clinical (site of 
disease, sputum smear status, and previous diagnosis of 
tuberculosis) characteristics of patients. We sent cluster 
investigation questionnaires to health-care workers in 
tuberculosis clinics to obtain information about social risk 
factors (history of alcohol or illicit drug use, homelessness, 
imprisonment), contact with a known drug-resistant case, 
and details of the contact investigation including personal 
identifi ers of contacts diagnosed with active disease. After 
molecular cluster assignation we sent a second 
questionnaire (cluster questionnaire)7 to health-care 
workers in all treating clinics to collect additional 
sociodemographic information (details of previous 
address, education, workplace, regular place of socialising, 
religious setting, prison, rehabilitation centre, homeless 
hostel, regular travel to or visitors from abroad or within 
the UK, all in the 2 years before diagnosis) for each 
clustered case. All questionnaires were completed by use 
of medical records and all were returned to the 
investigators. We obtained contact tracing notes from the 
tuberculosis clinics for each index case, when available. 
These notes contained information about the number of 
individuals screened (by Mantoux test or interferon γ 
release assay) and screening results for latent tuberculosis 
infection and active tuberculosis.
Laboratory methods
We did drug-susceptibility testing for all fi rst-line 
(isoniazid, rifampicin, pyrazinamide, ethambutol, and 
streptomycin) and second-line antibiotics (amikacin, 
capreomycin, kanamycin, moxifl oxacin, ofl oxacin, 
ethionamide, prothionamide, cycloserine, aminosalicylic 
acid, linezolid, and clofazimine) using the proportion or 
the resistance ratio method.8 We identifi ed one case of 
laboratory cross-contamination, confi rmed as not 
tuberculosis with the treating clinic and excluded. Strains 
showing borderline resistance to a drug were deemed to 
be resistant to that agent. We did retrospective strain 
typing using 24 MIRU-VNTR, as previously described,9 
on all initial MDR tuberculosis isolates, when available.
Cluster analysis
We combined MIRU-VNTR strain typing data with 
epidemiological information to identify links between 
patients and transmission settings. We assembled clusters 
on the basis of their MIRU-VNTR profi le. A cluster was 
defi ned as two or more patients with MDR tuberculosis 
with indistinguishable 24 loci MIRU-VNTR profi les, with 
at least 22 complete loci,10 notifi ed in the UK between 2004 
and 2007. Patients were clustered irrespective of 
geographical area of residence. We established the 
M tuberculosis lineage as previously described.11 We 
calculated the proportion of clustered cases using the 
n – 1 method12 (number of cases clustered–number of 
clusters / number of cases with a strain type). We used 
cluster questionnaires to identify common settings in 
which transmission could have occurred and to identify or 
confi rm epidemiological links between patients.
Epidemiological links were confi rmed if the patients 
named each other or lived at the same address; probable 
if patients were resident in London, had the same strain 
type and characteristics as patients with tuberculosis who 
were part of a known London outbreak,13 and did not 
name each other or live at the same address; possible if 
patients were linked through a common setting, other 
than the household, but did not name each other; or not 
linked if patients did not name each other and no 
common setting was identifi ed. These criteria were 
adapted from those defi ned in the national guidelines for 
cluster investigation.7 Transmission was confi rmed if 
clustered cases had a confi rmed epidemiological link. We 
adjusted the proportion of cases resulting from recent 
transmission in the UK by including only cases and 
clusters with confi rmed links in the calculation (number 
of cases with epidemiological links –number of clusters 
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with epidemiological links/number of cases with a strain 
type). We generated cluster diagrams displaying 
epidemiological links using Cytoscape desktop, which is 
an open source software package for building links 
between cases to form networks that can be annotated. 
We used BioNumerics (version 5.10) to generate the 
cluster assembly and the dendrogram.
Contact investigation
For each patient with MDR tuberculosis, we used contact 
investigation notes to identify secondary active 
tuberculosis cases that were not included in the original 
study population because they were notifi ed outside the 
study period or geographical area (Scotland), an isolate 
was unavailable for 24 loci MIRU-VNTR typing, or the 
isolate had a diﬀ erent MIRU-VNTR strain. Panel 1 shows 
defi nitions used in contact investigation. We obtained 
additional details about secondary cases from the 
enhanced tuberculosis surveillance system and, for one 
case, from the Scottish enhanced surveillance of 
mycobacterial infections system. 15 loci MIRU-VNTR 
typing was done in the UK before the introduction of 
24 loci MIRU-VNTR and was available from the 
Mycobacterial Surveillance Network (MycobNet) for 
cases not in the original study population. We compared 
drug susceptibility patterns and, when available, strain 
typing information between index and secondary cases to 
assess the likelihood of transmission.
Transmission between patients was confi rmed if 
isolates from the index and secondary cases had 
indistinguishable MIRU-VNTR profi les for the fi rst 
15 loci and the drug resistance pattern was consistent 
with transmission (patterns were the same or the isolate 
from the index case had resistance to fewer drugs than 
subsequent cases); possible if the strain type was not 
available for the secondary case but the drug resistance 
pattern was consistent with transmission; unknown if 
the strain type and drug resistance pattern of the 
secondary case were unavailable; or deemed not to have 
occurred if the MIRU-VNTR profi le was diﬀ erent or the 
drug resistance patterns of isolates were diﬀ erent (the 
secondary case was not MDR).
Statistical analysis
We used univariable and multivariable logistic regression 
modelling to calculate odds ratios (ORs) for factors 
associated with being in a cluster compared with having 
a unique strain. We used a forward stepwise approach to 
select the multivariable model with a probability entry of 
less than 0·2. We used Stata (version 12.0) for statistical 
analyses.
Role of the funding source
There was no external funding source for this study. LFA, 
ST, DZ, and IA had full access to all the data in the study. 
LFA had fi nal responsibility for the decision to submit 
for publication.
Results
Between 2004 and 2007, there were 32 578 notifi ed 
tuberculosis cases in the UK, of which 58·5% (19 059) were 
culture confi rmed; 99·1% (18 892) of culture-confi rmed 
cases had drug sensitivity results available for at least 
isoniazid and rifampicin. 204 individuals were diagnosed 
with culture-confi rmed MDR tuberculosis of whom 
189 (92·6%) had MIRU-VNTR profi les. Most individuals 
with MDR tuberculosis were aged 15–44 years old 
(170 of 204; 83·3%), non-UK born (170 of 201; 84·6%), had 
pulmonary disease (143 of 204; 70·1%), and had no previous 
diagnosis of tuberculosis (128 of 184; 69·6%). The outcomes 
of treatment of these cases have been described previously.14
Of 189 cases with MIRU-VNTR profi les, lineages could 
be assigned to 184 (97·4%). The most common lineage 
was Euro-American (78; 42·4%) followed by east African-
Indian (44; 23·9%), Beijing (42; 22·8%), Indo-Oceanic 
(16; 8·7%), and Mycobacterium africanum (4; 2·2%). We 
identifi ed 12 clusters containing 40 individuals (table 1) 
and 149 unique strains. The proportion of cases 
attributable to recent transmission, on the basis of 
molecular data only, was 15% (40 cases clustered–12 
clusters/189 cases with a strain type). Cluster size ranged 
from two to 12 cases: 35% (14 of 40) were in small clusters 
(of two cases), 35·0% (14) were in medium clusters (of 
three or four cases), and 30% (12 of 40) were in one large 
cluster (of 12 cases). The strains of most clustered cases 
were Euro-American (18 of 40; 45·0%) or Beijing 
(16 of 40; 40·0%).
We identifi ed epidemiological links in half the clusters 
(six of 12; a total of 22 cases with known, probable, or 
possible links; table 1, fi gure), and in these clusters the 
household was the most common transmission setting 
(ten of 22; 45%). In all these clusters, the fi rst case was 
For more on Cytoscape see 
http://www.cytoscape.org
Panel 1: Defi nitions used in contact investigation
Index case
A culture confi rmed MDR tuberculosis case notifi ed in the UK 
between 2004 and 2007. The fi rst MDR tuberculosis case to be 
notifi ed.
Contact
A person named as a contact by the index case.
Secondary case
(1) A contact who was named by the index case, screened, 
and was subsequently found to have active tuberculosis. 
Although this individual was notifi ed later this individual 
could also be deemed the source of infection or source case 
for the index case. For example, in reverse contact tracing of a 
child or if the secondary case had an earlier onset of 
symptoms.
(2) A person who was not identifi ed for screening initially but 
presented later with active tuberculosis and reported contact 
with an index case.
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pulmonary sputum smear positive and drug-resistance 
patterns were consistent with transmission. In four 
clusters, the fi rst case was non-UK born and in three of 
these clusters there was transmission to individuals 
from the same countries of birth (clusters 1, 2, and 5). 
We also identifi ed confi rmed transmission from non-
UK-born individuals to non-white-UK-born individuals 
of the same ethnicity (clusters 1 and 6). The largest 
cluster of 12 patients (cluster 1) was a known outbreak 
that began in 20044 (fi gure). Although only three of 
12 patients had epidemiological links confi rmed, 
sociodemographic factors and links through the 
community, workplace, and drug use suggested that 
spread to the other seven patients was likely. A cluster of 
four patients with MDR tuberculosis (cluster 3) were 
part of the isoniazid mono-resistant outbreak in 
London13 associated with UK-born individuals of white 
or black Caribbean ethnicities with social risk factors. At 
least one of these four patients acquired rifampicin 
resistance through non-compliance.
Of the 22 cases in clusters with epidemiological links, 
95% (21) of links were not identifi ed through conventional 
contract tracing. Household contacts were not disclosed 
by the index case because they had not been living at the 
same address at the time of diagnosis, they were an 
undisclosed frequent visitor, or were a temporary resident 
and had moved on. The proportion of cases attributable to 
recent transmission (ie, transmission within the UK) after 
adjustment for epidemiological links was 8·5% (22 cases 
with epidemiological links–six clusters/189 cases with a 
strain type).
Six clusters had no epidemiological links identifi ed 
(table 1). Patients within each of these clusters were born 
in the same geographical region and were from countries 
with a high tuberculosis burden. The fi rst case in each 
cluster was extrapulmonary or pulmonary sputum smear 
negative, suggesting that transmission in the UK was not 
likely. Although one cluster (cluster 12) contained both 
UK and non-UK-born individuals, patients had diﬀ ering 
drug resistance patterns, UK-born patients had links to 
Strain type Lineage Number 
of cases
Country of 
birth
Ethnicities Index case 
non-UK 
born
Index case 
pulmonary 
smear positive
Risk factors Epidemiological 
link
Transmission 
setting
1 424352332517333456443372 Beijing 12 5 UK, 2 Angola, 
1 Iran, 2 Latvia, 
1 Nigeria, 
1 unknown
6 black African; 
2 black Caribbean;
2 mixed/other;
1 white;
1 Indian;
none of UK born 
cases were white 
Yes Yes Drug use (4) Yes Household, 
work, and social
2 422342442517332442423374 East African/
Indian
2 India Indian Yes Yes No Yes Place of worship
3 424332431515321236423-52 Euro-
American
4 UK 2 black Caribbean; 
2 white
No Yes Drugs, 
prison, 
homeless, 
alcohol (3)
Yes Unknown
4 3242325125113223324433-3 Euro-
American
2 UK 2 white No Yes No Yes Household
5 3243225125113223324433-3 Euro-
American
3 2 Afghanistan; 
1 UK
2 mixed/other; 
1 Pakistani
Yes Yes No Yes Household
6 3233324125163244344434-3 Euro-
American
3 2 UK; 
1 India
3 Indian Yes Yes No Yes Household and 
work
7 424332331515321234423-52 Euro-
American
2 Nigeria 2 black African Yes No No No  Unknown
8 222321432615324332413262 Euro-
American
2 India 2 Indian Yes No No No  Unknown
9 224321532615327332413292 Euro-
American
2 Lithuania 2 white Yes No No No  Unknown
10  -2225254251633354-423384 East African 
Indian
2 1 India; 
1 Pakistan
1 Indian; 
1 Pakistani
Yes No No No  Unknown
11 4223426425173234424434-4 East African 
Indian
2 Pakistan 2 Pakistani Yes No No No Contact with 
MDR tuberculosis 
identifi ed abroad
12 424352332515333456443382 Beijing 4 2 UK; 
1 Bangladesh; 
1 China
2 white; 
1 Bangladeshi; 
1 Chinese
No Yes No No Contact with 
MDR tuberculosis 
identifi ed abroad
MDR=multidrug-resistant. 
Table 1: Characteristics of clusters
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countries of high tuberculosis burden through family or 
occupation, and non-UK-born patients were recent 
entrants (ie, within the year before diagnosis), reducing 
the likelihood of transmission in the UK.
Table 2 shows results of the univariable analysis. In the 
multivariable analysis, being UK born (adjusted OR 4·81; 
95% CI 2·03–11·36; p=0·0005) and a history of illicit 
drug use (adjusted OR 4·75; 95% CI 1·19–18·96; 
p=0·026) were independently associated with clustering. 
After adjustment for place of birth and drug use, being a 
prisoner was no longer signifi cantly associated with 
clustering (adjusted OR 1·05; 95% CI 0·85–12·73, 
p=0·975) and was not included in the fi nal model.
Most of the 204 patients with MDR tuberculosis had 
contact tracing information available (187; 91·7%). For 
187 MDR tuberculosis index cases, 1650 contacts were 
identifi ed for screening, of whom 1472 (89·2%) were 
screened: 70 had latent infection (attack rate=4·8%) and 
Figure: Clusters with epidemiological links
Each symbol (triangle or circle) represents a case in the cluster. Place of birth, ethnicity, epidemiological links identifi ed between cases and the type of link (confi rmed, 
possible, probable, or none) are indicated in the key. The likely transmission setting is stated next to the link. Site of disease and the date of notifi cation are shown 
directly above or below the case. In clusters 1 and 3 broader transmission settings are indicated by shaded circles around the cases. The dendrogram provides a display 
of how closely related the strains are in terms of the percentage of similarity between mycobacterial interspersed repetitive-unit–variable-number tandem repeat 
profi les. This percentage is shown at each node between branches. 
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nine were diagnosed with active disease (attack rate=0·6%). 
These nine secondary cases were associated with eight 
index cases. A further fi ve secondary cases occurred in 
individuals who were not identifi ed for screening but self-
referred when they became symptomatic and reported 
contact with an MDR tuberculosis index case. We excluded 
one index case and one secondary case from further 
analysis of laboratory results because they had already been 
identifi ed in an MIRU-VNTR cluster. Therefore, there were 
a total of 13 secondary cases from 11 index cases.
All 11 index cases and 12 of 13 secondary cases were 
non-UK-born. 11 of 13 secondary cases shared the same 
world region of birth as the index case, which was most 
commonly the Indian subcontinent (table 3). All 
secondary cases were linked to the index case through 
the household but fi ve were not identifi ed through 
conventional contract tracing because they had 
previously lived at the same address as the index case 
but did not at the time of diagnosis.
We examined strain types and drug sensitivities to 
establish whether transmission between index and 
secondary cases was likely (table 3). Only two secondary 
cases had isolates with 15 loci MIRU-VNTR strain types 
indistinguishable from the index case (index 1 and 2). 
Both of the index cases had pulmonary sputum smear-
positive disease. Isolates from secondary cases were 
resistant to an additional drug compared with isolates 
from the index cases (table 3), which is consistent with 
transmission. Five isolates from secondary cases had 
diﬀ erent drug-resistance patterns or strain types, or both, 
compared with the index cases (index 3–7). Only one 
secondary case had MDR tuberculosis and was thought 
to be the source of infection.
Drug susceptibility testing was unavailable for fi ve 
secondary cases (index 6 and 8–11). Two were treated as 
fully sensitive and successfully completed treatment 
within 12 months. Neither had relapsed as of Oct 1, 2013. 
Three were treated for MDR tuberculosis; a non-UK-
born child who was in contact with two cases of MDR 
tuberculosis in the household (index 6), a UK-born child 
with a sputum smear-positive mother from a country 
with high tuberculosis incidence (index 10), and a non-
UK-born mother with extrapulmonary disease who was 
identifi ed through contact tracing of her child (index 11).
Discussion
Between 2004 and 2007, we estimate that the proportion 
of MDR tuberculosis cases attributable to recent 
transmission, on the basis of molecular data, was 15%. 
Being UK born and illicit drug use were signifi cantly 
associated with clustering. The proportion of cases 
attributable to recent transmission within the UK, after 
adjustment for epidemiological links, was 8·5%. The 
most common trans mission setting was the household 
but for most clustered cases, epidemiological links 
were missed by conventional contact tracing. Secondary 
active tuberculosis cases identifi ed by conventional 
contact tracing were contacts of patients with MDR 
tuberculosis from countries of high tuberculosis 
burden. Most shared the same country of birth as the 
index case but did not share a strain type or drug 
resistance pattern.
The fi ndings of this study can be used to target 
interventions to reduce transmission and subsequently 
incidence of MDR tuberculosis in the UK and in Europe, 
Clustered
(n=40)
Unique
(n=149)
Unadjusted 
odds ratio
(95% CI)
p value
n (%) n (%)
UK born (n=186)
Yes 16 51·6 15 48·4 5·82 (2·54–13·3) <0·001
No 24 15·5 131 84·5 1·00 ··
Illicit drug use
Yes 7 58·3 5 41·7 6·11 (1·82–20·45) 0·004
No or unknown 33 18·6 144 81·4 1·00 ··
Alcohol use
Yes 4 33·3 8 66·7 1·96 (0·56–6·87) 0·311
No or unknown 36 20·3 141 79·7 1·00 ··
Homeless
Yes 3 33·3 6 66·7 1·93 (0·46–8·09) 0·385
No or unknown 37 20·6 143 79·4 1·00 ··
Prison
Yes 3 60·0 2 40·0 5·96 (0·96–36·97) 0·055
No or unknown 37 20·1 147 79·9 1·00 ··
Age group
0–14 years 5 38·5 8 61·5 2·48 (0·46–13·5) 0·505
15–44 years 31 20·1 123 79·9 1·00 ··
45–64 years 3 20·0 12 80·0 1·00 (0·26–3·79) ··
≥65 years 1 14·3 6 85·7 0·66 (0·56–7·85) ··
Sex
Male 20 20·8 76 79·2 1·00 0·910
Female 20 21·5 73 78·5 1·04 (0·52–2·09) ··
Ethnicity (n=185)
White 8 36·4 14 63·6 2·95 (1·02–8·57) 0·183
Black African 10 18·9 43 81·1 1·20 (0·48–3·03) ··
Indian subcontinent 12 16·2 62 83·8 1·00 ··
Other 10 27·8 26 72·2 1·98 (0·76–5·17) ··
Years since entry to the UK (n=116)
0–2 5 17·2 24 82·8 1·00 0·328
3–4 0 0 0 0 Not estimable ··
5–10 8 32·0 17 68·0 2·25 (0·63–8·11) ··
>10 years 19 30·6 43 69·4 2·12 (0·70–6·40) ··
Site of disease
Pulmonary sputum smear positive 21 25·6 61 74·4 1·00 0·330
Pulmonary sputum smear other 11 20·4 43 79·6 0·74 (0·32–1·69) ··
Extrapulmonary 8 15·1 45 84·9 0·52 (0·21–1·27) ··
Previous diagnosis (n=173)
Yes 8 15·4 44 84·6 1·00 0·159
No 30 24·8 91 75·2 1·81 (0·77–4·28) ··
Table 2: Univariable analysis of risk factors associated with multidrug-resistant tuberculosis clusters in the UK
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as part of the European tuberculosis control and 
elimination strategy in low-incidence countries (panel 2).16,17
Our estimate that about one in 12 cases of MDR 
tuberculosis resulted from transmission in the UK is 
lower than previously reported.4 This fi nding is much 
the same as that for MDR tuberculosis transmission in 
California for the same time period18 but lower than 
estimates from another study19 that showed that one in 
fi ve cases of MDR tuberculosis were the result of recent 
transmission across eight states in the USA. Our 
estimate is also substantially lower than that for MDR 
tuberculosis clustering for Europe,20 which was 43% and 
mainly attributable to Baltic states or former Soviet 
Union countries. By contrast, in a study from Ireland 
none of the MDR tuberculosis cases were clustered, 
although numbers were small.21 In our study, most 
cases with unique MDR tuberculosis strains were in 
individuals who were born outside of the UK and had 
recently arrived in the UK from countries with high 
tuberculosis burden, and therefore probably arose as a 
result of reactivation.
The two independent risk factors associated with 
transmission were being born in the UK and a history of 
illicit drug use. This fi nding is much the same as those 
from the USA19 where transmission of MDR tuberculosis 
was associated with being US born and drug or alcohol 
abuse. We identifi ed transmission among non-UK-born 
and non-white UK-born individuals of the same ethnicity, 
but there was no evidence of MDR tuberculosis 
transmission from non-UK-born individuals to white UK-
born individuals. This fi nding is indicative of transmission 
within specifi c communities in the UK. Among clusters, 
transmission was less likely if individuals with MDR 
tuberculosis were non-UK-born from the same country of 
Site of disease Number 
of contacts 
screened
Number 
of contacts 
with active 
disease
Number 
identifi ed 
through 
screening
World region of birth Same 
MIRU-VNTR 
profi le
Drug resistance pattern* Transmission
Index case Secondary case(s) Index case Secondary case
Index 
1
Pulmonary 
smear positive
59 1 0 Eastern Europe Eastern Europe Yes Isoniazid, rifampicin, 
streptomycin, 
pyrazinamide
Isoniazid, rifampicin, 
streptomycin, 
pyrazinamide, 
clofazimine
Confi rmed
Index 
2
Pulmonary 
smear positive
10 1 0 East Asia Indian 
subcontinent
Yes Isoniazid, rifampicin, 
streptomycin, 
ethambutol, 
pyrazinamide
Isoniazid, rifampicin, 
streptomycin, 
ethambutol, 
pyrazinamide, 
ethionamide
Confi rmed
Index 
3
Extrapulmonary 17 1 0 Indian 
subcontinent
Indian 
subcontinent
No Isoniazid, rifampicin Fully sensitive No
Index 
4
Extrapulmonary 3 1 1 Indian 
subcontinent
Indian 
subcontinent
No Isoniazid, rifampicin, 
streptomycin, 
pyrazinamide, 
ethambutol, 
ethionamide
Isoniazid No
Index 
5
Pulmonary other 3 1 1 Indian 
subcontinent
Indian 
subcontinent
Unknown Isoniazid, rifampicin, 
pyrazinamide, 
ethambutol
Fully sensitive No
Index 
6
Extrapulmonary 13 3 2 Sub-Saharan 
Africa
Sub-Saharan 
Africa
Unknown Isoniazid, rifampicin, 
ethambutol, 
streptomycin
1 fully sensitive, 2 no 
culture, 3 isoniazid, 
rifampicin
Possible
Index 
7
Pulmonary 
smear positive
8 1 1 Middle East Middle East Unknown Isoniazid, rifampicin, 
pyrazinamide, 
ethambutol, 
ethionamide, 
streptomycin
Isoniazid, 
streptomycin
No
Index 
8
Extrapulmonary 2 1 1 Sub-Saharan 
Africa
Sub-Saharan 
Africa
Unknown Isoniazid, rifampicin No culture Unknown
Index 
9
Pulmonary 
smear positive
4 1 1 Indian 
subcontinent
Indian 
subcontinent
Unknown Isoniazid, rifampicin, 
ethambutol
No culture Unknown
Index 
10
Pulmonary 
smear positive
3 1 1 Indian 
subcontinent
UK Unknown Isoniazid, rifampicin, 
pyrazinamide
No culture Unknown
Index 
11
Pulmonary other 11 1 1 Indian 
subcontinent
Indian 
subcontinent
Unknown Isoniazid, rifampicin, 
streptomycin
No culture Unknown
MIRU-VNTR=mycobacterial interspersed repetitive-unit-variable-number tandem repeat. 
Table 3: Characteristics of index and secondary cases
Articles
www.thelancet.com/infection   Vol 14   May 2014 413
birth, which is probably indicative of importations of 
common strains from abroad.
National guidance7 issued in 2011 for cluster 
investigation in the UK recommends that all clusters of 
two or more MDR tuberculosis cases should be 
investigated for recent transmission irrespective of other 
risk factors. Our fi ndings suggest that clusters involving 
individuals with MDR tuberculosis who are UK born or 
have social risk factors, such as illicit drug use, should be 
investigated with greater urgency than clusters of cases 
from the same foreign country of birth. Non-UK born 
patients, who are part of a cluster and have no 
epidemiological links identifi ed, probably acquired a 
common strain of tuberculosis from abroad and 
subsequently reactivated after entering the UK.
Beijing strains accounted for only 22% of all strains, 
but this lineage was associated with a high proportion of 
clustered strains (40%); however, this fi nding is mostly 
attributable to one large cluster of 12 cases. Some 
evidence suggests that Beijing MDR tuberculosis strains 
are more transmissible than MDR tuberculosis strains of 
other lineages.22,23 However, this association could also be 
attributed to immigration from countries with a high 
prevalence of both Beijing strains and MDR tuberculosis 
or alternatively, Beijing strains might be less likely to 
diﬀ er by MIRU-VNTR profi le because they evolved more 
recently than other strains.24
Contact investigation among household contacts is a 
routine part of tuberculosis control in the UK.25 
Nevertheless, in our study a substantial proportion of 
household contacts who were diagnosed as secondary 
cases were missed by conventional contact tracing. Results 
of a large meta-analysis26 of contact screening showed that 
in high-income countries active tuberculosis among 
contacts of individuals with MDR or XDR tuberculosis 
was 0% but the proportion of contacts with latent infection 
was 52·6% (95% CI 49·5–55·7%).26 We identifi ed a much 
lower proportion of latent infections in the UK, which 
suggests that additional contacts might have been missed. 
Possible reasons for failing to identify these contacts 
include reluctance to disclose household contacts, the 
non-disclosure of visiting household contacts, and the 
failure to identify temporary residents who had moved on. 
The use of peer support and workplace and home visits 
can improve contact identifi cation.27 In the largest cluster, 
links were often suspected but never confi rmed because 
of the involvement of illicit drug use and because infected 
individuals were reluctant to name contacts. Traditional 
name-based contact identifi cation has limitations in some 
high-risk groups, in which contacts identifi ed by methods 
other than naming are more likely to be infected than 
named contacts.28–31 Use of a dedicated outreach service 
targeting high-risk popu lations in specifi c settings is 
eﬀ ective in active case fi nding to tackle tuberculosis in 
these groups.32
This study provides evidence that the epidemiological 
investigation of MDR tuberculosis MIRU-VNTR clusters 
was more successful at identifying cases in the same 
chain of transmission than conventional contract tracing. 
Sintchenko and colleagues15 showed that second 
interviews for clustered cases could optimise detection of 
epidemiological links and secondary cases if the 
occurrence of clustering was at least 4%. The UK 
recommends this strategy as part of the National Strain 
Typing Service in which a combination of prospective 
strain typing and social networking questionnaires are 
used to identify transmission chains and inform public 
health action.7 In regions with a high tuberculosis case-
load clinical case managers might fi nd it diﬃ  cult to 
provide epidemiological information to health protection 
teams in a timely manner. The introduction of local 
public health oriented teams employing staﬀ  dedicated to 
cluster investigation would ensure rapid identifi cation of 
transmission settings and subsequent contact screening.
In this study, household contacts of non-UK born 
patients with MDR tuberculosis, who developed active 
disease, were more likely to have a diﬀ erent strain of 
tuberculosis than a strain indistinguishable from that of 
the index case. These individuals were from countries 
with high tuberculosis burden where the risk of exposure 
to diﬀ erent circulating strains is substantial, resulting in 
several strains within one household.33–35
Panel 2: Research in context
Systematic review
We searched PubMed using the terms “multi-drug resistant tuberculosis/MDR-TB”, 
“transmission”, “genotyping”, “clustering”, “outbreak”, “MIRU-VNTR”, “mycobacterial 
interspersed repetitive-unit-variable-number tandem repeat”, “risk factors”, “contact 
tracing”, and “active case fi nding”, alone and in combination. About a fi fth of multidrug 
resistant tuberculosis cases arising in the UK were previously estimated to result from 
recent transmission.4 This study was based on 15 loci MIRU-VNTR typing, which has a 
lower discriminatory power than 24 loci MIRU-VNTR typing, which is now routinely used 
in the UK to inform cluster investigation. Additionally, in the previous study4 
epidemiological links between cases were not taken into account and it therefore 
probably overestimated the amount of multidrug-resistant (MDR) tuberculosis 
transmission. There was no transmission of extensively drug-resistant tuberculosis in the 
UK between 1995 and 2007.5 Whether conventional contact tracing eﬀ ectively identifi es 
MDR tuberculosis cases in a true transmission chain is unclear and risk factors for 
transmission of MDR tuberculosis in the UK are unknown. Identifi cation of risk factors for 
transmission is crucial to establish specifi c resources that are needed for timely targeted 
public health interventions to control tuberculosis and to prevent further transmission of 
drug-resistant tuberculosis in the UK.
Interpretation
As far as we are aware, this study is the fi rst to combine molecular, contact tracing, and 
epidemiological information for a detailed investigation of MDR tuberculosis 
transmission in the UK. We have shown that transmission of MDR tuberculosis in the UK 
is lower than previously estimated4 at 15%, which decreased to 8·5% after taking 
epidemiological links into account. This study has shown the benefi ts of using strain 
typing data and cluster investigation to detect transmission chains, which increases the 
likelihood of additional active cases being detected and diagnosed early.15 It has also 
shown the need for improved contact tracing, which can be addressed through training 
and resourcing frontline staﬀ . 
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Some secondary cases were treated with the same MDR 
regimen as the index case, as recommended,36 whereas 
others were treated empirically as fully sensitive cases. 
Attempts to obtain samples for culture confi rmation and 
drug-susceptibility testing are essential for household 
contacts of non-UK-born individuals with MDR 
tuberculosis from countries of high tuberculosis burden to 
minimise inappropriate use of drug regimens and 
exposure of patients to serious side-eﬀ ects. A com-
prehensive risk assessment for drug resistance should be 
done in all cases and provision of additional advice from 
dedicated MDR tuberculosis networks37,38 should be 
encouraged. The management of contacts of individuals 
with MDR tuberculosis who are latently infected remains 
challenging because evidence for best practice is scarce, 
therefore further work in this area is welcomed.
A strength of this study is the methodological design in 
which a combination of epidemiological and strain 
typing data, including data obtained from cluster 
investigation, was used for an in-depth investigation and 
analysis of factors associated with transmission of MDR 
tuberculosis in the UK. Robust methods for data 
validation and completeness, the high proportion of 
contact tracing notes available at clinics, and the high 
coverage of strain typing provides confi dence that the 
fi ndings are accurate and can be generalised to similar 
MDR tuberculosis populations, such as those of other 
countries with low tuberculosis incidence.
Some factors in this study might have led to the 
overestimation of MDR tuberculosis transmission in the 
UK. A genotyping method with higher discriminatory 
power, such as whole genome sequencing, might have 
detected molecular diﬀ erences between clustered 
strains.39 This limitation might explain why links were 
only detected in half the clusters—ie, the clusters without 
links might not have been true clusters.
Transmission might have been underestimated if 
secondary cases did not admit to having contact with 
one of the index cases. Additional secondary cases 
might have left the UK either before reactivation or 
diagnosis. Undiagnosed cases of MDR tuberculosis or 
those without culture will also have been excluded from 
clusters. However, the existence of many undiagnosed 
cases of MDR tuberculosis is unlikely because of the 
widespread availability of drug-susceptibility testing of 
culture-confi rmed cases in the UK. Only about 60% of 
tuberculosis cases in the UK are culture confi rmed;3 
low culture confi rmation is partly driven by the high 
proportion of cases with extrapulmonary tuberculosis, 
and means additional cases with epidemiological links 
might have been missed. Furthermore, in the UK 
strains with single locus variants are deemed to be 
diﬀ erent but there is now evidence, from next 
generation sequencing, to show that genetically linked 
strains can diﬀ er by one or two MIRU-VNTR loci,39 
which might have also underestimated transmission in 
this study.
We note that although ORs and risk ratios will be 
similar when the outcome is rare, the outcome 
(clustering) is not uncommon in our study at 15%. 
Therefore ORs will tend to be slightly more extreme than 
their corresponding risk ratio, although calculating risk 
ratios (data not shown) did not aﬀ ect the signifi cance or 
interpretation of results.
Although clustering of MDR tuberculosis was most 
strongly associated with being UK-born and injection 
drug use, we also detected transmission in non-UK-born 
populations and ethnic communities, with little trans-
mission between communities. Targeted approaches are 
needed to prevent further transmission in these 
communities, through awareness strategies, active case 
fi nding among the UK-born population with social risk 
factors in specifi c settings, and screening of migrant 
populations from countries with a high incidence of 
MDR tuberculosis. The process that case managers use 
for interviews for contact identifi cation needs to be 
reviewed to establish the type of training and resources 
needed to enhance contact identifi cation. Cluster data 
should also be made available to clinical teams in a 
timely manner to direct contact tracing.
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